Syndrome of inappropriate antidiuretic hormone secretion following irinotecan-cisplatin administration as a treatment for recurrent ovarian clear cell carcinoma

  • Kwon, Do-youn; 
  • Han, Gwanhee; 
  • Ulak, Roshani; 
  • Ki, Kyoungdo; 
  • Lee, Jong-min; 
  • 외 1명
Citations

SCOPUS

7

초록

Syndrome of inappropriate antidiuretic hormone secretion (SIADH) has various causes including central nervous system disorders, pulmonary and endocrine diseases, paraneoplastic syndromes, and use of certain drugs. SIADH induced by chemotherapy with irinotecan-cisplatin is not a common complication. Here, we review a case of SIADH after treatment with irinotecan-cisplatin. A 45-year-old woman received adjuvant chemotherapy (paclitaxel-carboplatin) for ovarian clear cell carcinoma, but the cancer recurred within 9 months of chemotherapy. Subsequently, a second line of combination chemotherapy containing irinotecan-cisplatin was initiated. However, 5 days after chemotherapy administration, her general condition began to deteriorate; her hematological tests revealed hyponatremia. Therefore, it is imperative to consider the possibility of SIADH in patients being treated with irinotecan-cisplatin- based chemotherapy. Proper monitoring of serum sodium levels and assessment of clinical symptoms should be performed in such patients for early diagnosis and prompt management. © 2017 Korean Society of Obstetrics and Gynecology.

키워드

Cisplatin; Clear cell; Inappropriate ADH syndrome; Irinotecan; Ovarian cancer
제목
Syndrome of inappropriate antidiuretic hormone secretion following irinotecan-cisplatin administration as a treatment for recurrent ovarian clear cell carcinoma
저자
Kwon, Do-youn; Han, Gwanhee; Ulak, Roshani; Ki, Kyoungdo; Lee, Jong-min; Lee, Seon-kyung
DOI
10.5468/ogs.2017.60.1.115
발행일
2017-01
유형
Article
저널명
Obstetrics & Gynecology Science
권
60
호
1
페이지
115 ~ 117

파일 다운로드

Thumbnail